Curcumin ameliorates memory decline via inhibiting BACE1 expression and β-Amyloid pathology in 5× FAD transgenic mice
10.1007/s12035-016-9802-9 · doi-reference
Curcumin mediates presenilin-1 activity to reduce β-amyloid production in a model of Alzheimer’s disease
10.1016/s1734-1140(11)70629-6 · doi-reference
Paeoniflorin atttenuates amyloidogenesis and the inflammatory responses in a transgenic mouse model of Alzheimer’s disease
10.1007/s11064-015-1632-z · doi-reference
Berberine attenuates calyculin A-induced cytotoxicity and Tau hyperphosphorylation in HEK293 cells
10.3233/jad-2011-101779 · doi-reference
Cellular and molecular mediators of neuroinflammation in Alzheimer disease
10.5213/inj.1938184.092 · doi-reference
1, 3-Dichloro-2-propanol evokes inflammation and apoptosis in BV-2 microglia via MAPKs and NF-κB signaling pathways mediated by reactive oxygen species
10.1016/j.toxlet.2017.12.011 · doi-reference
Therapeutic approaches targeting apolipoprotein E function in Alzheimer’s disease
10.1186/s13024-020-0358-9 · doi-reference
Potential benefits of phytochemicals against Alzheimer’s disease
10.1017/s0029665116002962 · doi-reference
Role of reactive oxygen species in LPS‐induced production of prostaglandin E2 in microglia
10.1046/j.1471-4159.2003.02242.x · doi-reference
Honokiol attenuates oligomeric amyloid β1-42-induced Alzheimer’s disease in mice through attenuating mitochondrial apoptosis and inhibiting the nuclear factor kappa-B signaling pathway
10.1159/000480320 · doi-reference
Grape-derived polyphenolics prevent Aβ oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease
10.1523/jneurosci.0364-08.2008 · doi-reference
Piperine regulates glycogen synthase kinase-3β-related signaling and attenuates cognitive decline in D-galactose-induced aging mouse model
10.1016/j.jnutbio.2019.108261 · doi-reference
Resveratrol‐enhanced autophagic flux ameliorates myocardial oxidative stress injury in diabetic mice
10.1111/jcmm.12312 · doi-reference
Resveratrol: A review of plant sources, synthesis, stability, modification and food application
10.1002/jsfa.10152 · doi-reference
Models of β-amyloid induced Tau-pathology: the long and “folded” road to understand the mechanism
10.1186/1750-1326-9-51 · doi-reference
Nuclear factor-kappa B: glucocorticoid-induced leucine zipper interface analogs suppress pathology in an Alzheimer’s disease model
10.1016/j.trci.2018.04.004 · doi-reference
Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer’s disease and multiple sclerosis
10.1517/14728222.2014.989834 · doi-reference
Challenges for research on polyphenols from foods in Alzheimer’s disease: bioavailability, metabolism, and cellular and molecular mechanisms
10.1021/jf0735073 · doi-reference
BAG-1M co-activates BACE1 transcription through NF-κB and accelerates Aβ production and memory deficit in Alzheimer’s disease mouse model
10.1016/j.bbadis.2017.05.014 · doi-reference
Pharmacological actions of berberine on the central nervous system
10.1254/jjp.20.482 · doi-reference
Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer’s disease
10.1016/j.phrs.2017.11.030 · doi-reference
Resveratrol confers neuroprotection against high-fat diet in a mouse model of Alzheimer's disease via modulation of proteolytic mechanisms
10.1016/j.jnutbio.2020.108569 · doi-reference
Artemisia amygdalina upregulates Nrf2 and protects neurons against oxidative stress in Alzheimer disease
10.1007/s10571-019-00656-w · doi-reference
An integrated bioinformatics strategy to elucidate the function of hub genes linked to Alzheimer's disease
10.1016/j.genrep.2022.101534 · doi-reference
NF-κB p65 directs sex-specific neuroprotection in human neurons
10.1038/s41598-018-34394-8 · doi-reference
A potential role of the curry spice curcumin in Alzheimer's disease
10.2174/1567205053585882 · doi-reference
The amyloid cascade hypothesis in Alzheimer's disease: it's time to change our mind
10.2174/1570159x15666170116143743 · doi-reference
Resveratrol and Neuroprotection: Impact and its Therapeutic Potential in Alzheimer's disease
10.3389/fphar.2020.619024 · doi-reference
Potential therapeutic role of phytochemicals to mitigate mitochondrial dysfunctions in Alzheimer’s disease
10.3390/antiox10010023 · doi-reference
Inhibition of nitric oxide in LPS-stimulated macrophages of young and senescent mice by δ-tocotrienol and quercetin
10.1186/1476-511x-10-239 · doi-reference
Curcumin-induced upregulation of the anti-tau cochaperone BAG2 in primary rat cortical neurons
10.1016/j.neulet.2013.09.008 · doi-reference
A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease
10.1038/s41582-018-0116-6 · doi-reference
Common germline variants of the human APOE gene modulate melanoma progression and survival
10.1038/s41591-020-0879-3 · doi-reference
Tau aggregation and its interplay with amyloid-β
10.1007/s00401-014-1371-2 · doi-reference
Synaptic dysfunction in Alzheimer's disease: From the role of amyloid β-peptide to the α-secretase ADAM10
10.1016/j.ejphar.2017.06.018 · doi-reference
Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's disease
10.1016/s0006-8993(98)00328-x · doi-reference
Oxidative stress and advanced lipoxidation and glycation end products (ALEs and AGEs) in aging and age-related diseases
10.1155/2019/3085756 · doi-reference
Post-translational modifications of tau protein: implications for Alzheimer's disease
10.1016/j.neuint.2010.12.023 · doi-reference
Bacteroides fragilis lipopolysaccharide and inflammatory signaling in Alzheimer’s disease
10.3389/fmicb.2016.01544 · doi-reference
Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease
10.1093/nar/gkm821 · doi-reference
